BioXcel Therapeutics Announces Positive Phase 2 Topline Results from Columbia University-Led Study of BXCL501 for Treatment of Opioid Withdrawal

BXCL501 demonstrated clinical benefits and favorable tolerability profile for treatment of opioid withdrawal symptoms Results from this ...
Stocktwits on MSN

Why did BTAI stock surge 20% in pre-market today?

Shares of BioXcel Therapeutics Inc (BTAI) surged nearly 20% in pre-market trading on Thursday, after the company announced positive topline results from a Phase 2 trial evaluating BXCL501 for treating ...

New Miami recovery center will be using a unique approach to help treat opioid addiction, focusing on withdrawal symptoms

The device, which is cleared by the FDA for withdrawal mitigation from opioid use disorder, works by abating severe symptoms such as stomach aches, back aches, sweats, and the inability to keep food ...

Muse Treatment Publishes In-Depth New Resource Examining the Dangers of Fentanyl-Laced Meth and Public Health Implications

LOS ANGELES, CA - March 04, 2026 - PRESSADVANTAGE - Muse Treatment Alcohol & Drug Rehab Los Angeles has published a ...

Prior authorization bans for buprenorphine alone may not improve treatment retention

State laws that ban insurance prior authorization for buprenorphine—a leading medication for opioid use disorder—may not help more patients stay in treatment for the recommended minimum of 180 days, ...
phillyvoice.com

Fentanyl withdrawal is driving more opioid users to leave hospitals early, Penn researchers say

Hospitals have faced mounting pressure in recent years to find better treatments for patients who are in the throes of opioid withdrawal. The challenge of safely managing these patients' symptoms is ...
MedPage Today on MSN

Amid Opioid Addiction Treatment, Losing Insurance Tied to Mortality Risk

Health insurance loss, changes "may undermine continuity of critical treatment," researche ...
KXLY

MultiCare introduces new opioid withdrawal treatment in Spokane emergency room

Health care workers in the Deaconess emergency department now have a new way to treat patients with opioid withdrawal symptoms: long-acting injectable buprenorphine.
PR Newswire

Opioid Withdrawal Syndrome Drug Market to Surge at a CAGR of 4.0% by 2034 | DelveInsight

Opioid Withdrawal Syndrome Pipeline Insight – 2024 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and ...

Los Angeles Addiction Crisis Highlights Need for Medically Supervised Detox and Residential Treatment

With Alcohol and Opioid Cases Rising, Bright Paths Recovery Highlights the Need for Safe Detox and Inpatient Treatment ...
Psychology Today

Opiate Drug Detox Treatment Centers in Maryland

Veni Vidi Vici Treatment Services provides FDA-approved medication, Methadone and Suboxone, combined with counseling and toxicology services for a highly effective approach to care for Opioid Use ...
Psychology Today

Opiate Drug Detox Treatment Centers in Durango, CO

The kind, experienced staff members at Regional Crisis Center—Durango offer different types of care to help meet your immediate needs. Our Acute Treatment Unit (ATU) provides short-term crisis ...